Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RN1701 in Relapsed/Refractory B-Cell Lymphomas
NCT07506668Phase 2Not yet recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- CAR-T Cells
01
Overview
A Phase 2 trial of RN1701 in B cell lymphoma, sponsored by Affiliated Hospital of Nantong University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
RN1701
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT07506668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07506668.